Recruiting Myelofibrosis Studies in Rochester
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
This phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofi...
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
This study evaluates TL-895, a potent, orally-available and highly selective irreversible tyrosine kinase inhibitor for the treatment of Myelofibrosis (Cohorts 1-3) or Indolent Systemic Mastocytosis (...
About Myelofibrosis Clinical Trials in Rochester
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 2 myelofibrosis clinical trials recruiting participants in Rochester, MINNESOTA. These studies are seeking a combined 271 participants. Research is being sponsored by Disc Medicine, Inc, Telios Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in Rochester — FAQ
Are there myelofibrosis clinical trials in Rochester?
Yes, there are 2 myelofibrosis clinical trials currently recruiting in Rochester, MINNESOTA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Rochester?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.
Are clinical trials in Rochester free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 2 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov